Deals & Cases
- Kellerhals Carrard with Seprify on Series A round and collaboration with Oterra
March 12, 2026 - Kellerhals Carrard advises Vsquared Ventures on AlphaLum’s CHF 3.4 Million Seed Financing Round
January 20, 2026 - Deal Ticker: Kellerhals Carrard supports Galenica to enter the diagnostics business by acquiring Labor Team
July 3, 2025 - Deal Ticker: Kellerhals Carrard advises TecMed on the Acquisition of Ypsomed Diabetes Care to Build Global Insulin Powerhouse
April 22, 2025 - Deal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AG
March 13, 2025 - Deal Ticker: Kellerhals Carrard advises Ego Death Capital on $12M Series A Funding Round for Relai
December 13, 2024 - Deal Ticker: Kellerhals Carrard advises Panakes Partners in the EUR 17.9 million Series B Financing Round of Lymphatica Medtech
October 16, 2024 - Orrick and Kellerhals Carrard for Partech in the Series C of xFarm
October 15, 2024 - Deal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AG
June 28, 2024 - Deal Ticker: Kellerhals Carrard Advises WellDev AG on Acquisition of InnoTix AG
March 7, 2024 - Deal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AG
August 9, 2023 - Dealticker - Orell Füssli acquires a majority stake in hep Verlag
July 8, 2022